Apr 24, 2020
Hackensack Meridian Health Develops RE-COV-RY (Real world Evidence - COVid-RegistrY) to Study the Effects of COVID-19 and Releases Key Findings on Hypertension and ACE/ARB Treatments
Mar 20, 2020
Antihypertensive Drugs Industry Outlook to 2027 by Drug, Condition, Medication Type, Distribution Channel and Region
Mar 11, 2020
Unhealthy Lifestyle Choices and Disturbed Work Life Balance to Lead Increased Sales of Antihypertensive Drugs Market; Valuation to Rise Up to US$33.9 Bn by 2027, Finds TMR
Feb 20, 2020
Ablative Solutions Announces Publication of Data from the Peregrine Post-Market Study in the Journal of the American College of Cardiology: Cardiovascular Interventions
Jan 15, 2020
Antihypertensive Drugs Market to Garner $28.79 Bn, Globally, by 2026 at 3.1% CAGR, Says Allied Market Research
Sep 25, 2019
Katerzia(TM), the First and Only Amlodipine Oral Suspension, 1 mg/mL, is Now Commercially Available for Pediatric Patients 6 Years of Age and Older
Sep 17, 2019
Geneticure Awarded Patent for Precision Medicine Blood Pressure Treatment
Jul 24, 2019
Better Therapeutics Demonstrates Proof of Concept in the Use of Digital Biomarkers to Improve Treatment Outcomes
Jun 25, 2019
Global Angiotensin Converting Enzymes (ACE) Inhibitors Market to Surpass US$ 12.4 Billion by 2026
Apr 18, 2019
TriNetX's Real-World Data and Analytics Platform Used to Compare Antihypertensive Treatments and Cardiovascular Events; Findings Published in the Journal of Clinical Hypertension
Apr 09, 2019
Geneticure Presents Data Demonstrating Potential of its Multi-Gene Weighted Algorithm to Lower Blood Pressure in Hypertension Patients
Apr 04, 2019
Global Antihypertensives Markets Report 2019: 2017 Data, Forecasts for 2018-2023 - Unmet Needs in Low- and Middle-Income Countries Presents Opportunities
Mar 19, 2019
The antihypertensive drugs market will register a CAGR of over 2% by 2023
Mar 19, 2019
Better Therapeutics Publishes New Study Demonstrating Rapid Reduction in Blood Pressure Among Hypertensive Adults
Mar 17, 2019
ReCor Medical Announces 6 Month On-Medication Results from RADIANCE-HTN SOLO Clinical Trial and the First Randomization in the RADIANCE-II Pivotal Study
Jan 28, 2019
Antihypertensives: Global Markets to 2023
Jan 11, 2019
Bernstein Liebhard LLP Evaluating Potential Valsartan Lawsuits for Cancer and Liver Injuries Allegedly Caused by Contaminated Heart and Blood Pressure Medications
Jan 09, 2019
China's Irbesartan (Sanofi's Aprovel) Markets 2018-2022
Nov 19, 2018
The Chinese Metoprolol Industry - Outlook to 2022: Guangzhou Baiyunshan Tianxin Pharmaceutical, Shanghai Sine Promod Pharmaceutical and Zhuhai Tongyuan Pharmaceutical are the Leading Players
Nov 10, 2018
The Association of Black Cardiologists collaborating with Quantum Genomics' NEW-HOPE Study, incorporating minority inclusivity, presents Late-Breaking Trial success of novel antihypertensive agent